D. E. Shaw & Co., Inc. - UNIQURE NV ownership

UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 96 filers reported holding UNIQURE NV in Q4 2018. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of UNIQURE NV
ValueSharesWeighting
Q3 2023$2,762,749
+1098.5%
411,736
+1946.9%
0.00%
Q2 2023$230,518
+9.3%
20,115
+78.0%
0.00%
Q2 2022$211,000
-91.4%
11,300
-83.3%
0.00%
-100.0%
Q4 2020$2,442,000
+23.0%
67,602
+25.4%
0.00%0.0%
Q3 2020$1,985,000
-57.0%
53,900
-47.4%
0.00%
-60.0%
Q2 2020$4,621,000
-4.1%
102,562
+1.0%
0.01%
-28.6%
Q1 2020$4,817,000
+12.0%
101,507
+69.1%
0.01%
+16.7%
Q4 2019$4,301,000
+36.0%
60,019
-25.3%
0.01%
+100.0%
Q3 2019$3,163,000
+19.4%
80,341
+137.0%
0.00%0.0%
Q2 2019$2,650,000
-63.8%
33,900
-72.4%
0.00%
-66.7%
Q1 2019$7,317,000
+755.8%
122,660
+313.6%
0.01%
+800.0%
Q4 2018$855,000
-65.5%
29,657
-56.5%
0.00%
-66.7%
Q3 2018$2,480,000
-32.4%
68,153
-29.8%
0.00%
-40.0%
Q2 2018$3,669,000
+60.9%
97,047
+0.0%
0.01%
+66.7%
Q1 2018$2,281,000
+9.4%
97,044
-8.8%
0.00%0.0%
Q4 2017$2,085,000
+409.8%
106,442
+330.1%
0.00%
+200.0%
Q4 2015$409,000
-59.9%
24,748
-50.3%
0.00%
-50.0%
Q3 2015$1,019,000
+50.3%
49,838
+98.6%
0.00%
+100.0%
Q2 2015$678,000
+202.7%
25,100
+3.3%
0.00%
Q3 2014$224,00024,2870.00%
Other shareholders
UNIQURE NV shareholders Q4 2018
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 155,500$11,803,0002.66%
Aquilo Capital Management, LLC 901,490$16,290,0002.39%
Nantahala Capital Management 2,811,459$50,803,0002.25%
Privium Fund Management B.V. 493,229$8,913,0001.97%
683 Capital Management, LLC 1,355,000$24,485,0001.31%
Henry James International Management Inc. 125,622$2,270,0000.90%
Integral Health Asset Management, LLC 170,000$3,072,0000.80%
Nantahala Capital Management 890,000$16,082,0000.71%
Sonic Fund II, L.P. 50,000$904,0000.51%
Voss Capital, LLC 70,000$1,265,0000.40%
View complete list of UNIQURE NV shareholders